$ Value
$0
Shares
125,094
Price
$0
Filed
Feb 18
Insider
Name
MORRISSEY MICHAEL
Title
President and CEO
CIK
0001202096
Roles
Transaction Details
Transaction Date
2026-02-18
Code
G
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
2,090,234
Footnotes
Includes 1,454,115 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. | Represents a "net exercise" of an outstanding stock option to purchase 494,700 shares, and pursuant to which the Reporting Person received 125,094 shares of Common Stock. The Issuer withheld 369,606 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using the closing stock price on January 13, 2026 of $43.92. | Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 16, 2025. | On February 17, 2026, the Reporting Person gifted 250,736 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. | Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. | On February 18, 2026, the Reporting Person gifted 125,094 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. | Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 13, 2026. | The option, representing the right to purchase a total of 494,700 shares of Common Stock, became fully exercisable on March 4, 2025.
Filing Info
MORRISSEY MICHAEL's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-26 | EXEL | A | $0 |
| 2026-02-24 | EXEL | G | $0 |
| 2026-02-18 | EXEL | G | $0 |
| 2026-02-18 | EXEL | G | $0 |
| 2026-02-17 | EXEL | G | $0 |
| 2026-02-17 | EXEL | G | $0 |
| 2026-02-15 | EXEL | F | $5.3M |
| 2026-02-13 | EXEL | M | $10.5M |
| 2026-02-13 | EXEL | F | $16.2M |
| 2026-02-13 | EXEL | M | $0 |
Other Insiders at EXEL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| WYSZOMIERSKI JACK L | — | $4.4M | 2026-02-18 |
|
MORRISSEY MICHAEL
President and CEO
|
— | — | 2026-02-26 |
| Smith Julie | — | $4.7M | 2026-02-18 |
|
Senner Christopher J.
EVP and CFO
|
— | $2.8M | 2026-02-26 |
|
Haley Patrick J.
EVP, Commercial
|
— | $3.0M | 2026-02-26 |
| Oliver Bob | — | $1.3M | 2026-02-13 |
| Eckhardt Sue Gail | — | $169K | 2026-02-13 |
|
Aftab Dana
EVP, Research and Development
|
— | $3.5M | 2026-02-26 |
|
Hefti Brenda
SVP and General Counsel
|
— | $822K | 2026-02-26 |